These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 33810779)
1. In vitro activity of plazomicin against quinolone-resistant gram-negative bacteria isolated from catheter-associated urinary tract infections. Abd-Elmonsef MME; Nagla S; Afandy ME; Maxwell SY J Chemother; 2021 Nov; 33(7):462-468. PubMed ID: 33810779 [TBL] [Abstract][Full Text] [Related]
2. Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms. Castanheira M; Deshpande LM; Woosley LN; Serio AW; Krause KM; Flamm RK J Antimicrob Chemother; 2018 Dec; 73(12):3346-3354. PubMed ID: 30219857 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of Plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in US Census divisions. Castanheira M; Davis AP; Serio AW; Krause KM; Mendes RE Diagn Microbiol Infect Dis; 2019 May; 94(1):73-77. PubMed ID: 30661726 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012. Walkty A; Adam H; Baxter M; Denisuik A; Lagacé-Wiens P; Karlowsky JA; Hoban DJ; Zhanel GG Antimicrob Agents Chemother; 2014 May; 58(5):2554-63. PubMed ID: 24550325 [TBL] [Abstract][Full Text] [Related]
7. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance. Galani I; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Souli M; BMC Infect Dis; 2019 Feb; 19(1):167. PubMed ID: 30770727 [TBL] [Abstract][Full Text] [Related]
8. Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections. Eljaaly K; Alharbi A; Alshehri S; Ortwine JK; Pogue JM Drugs; 2019 Feb; 79(3):243-269. PubMed ID: 30723876 [TBL] [Abstract][Full Text] [Related]
9. Activity of plazomicin in combination with other antibiotics against multidrug-resistant Enterobacteriaceae. Thwaites M; Hall D; Stoneburner A; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C Diagn Microbiol Infect Dis; 2018 Dec; 92(4):338-345. PubMed ID: 30097297 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers. Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE). Zhang Y; Kashikar A; Bush K J Antimicrob Chemother; 2017 Oct; 72(10):2792-2795. PubMed ID: 29091224 [TBL] [Abstract][Full Text] [Related]
12. Plazomicin: an intravenous aminoglycoside antibacterial for the treatment of complicated urinary tract infections. Bilinskaya A; Linder KE; Kuti JL Expert Rev Anti Infect Ther; 2020 Aug; 18(8):705-720. PubMed ID: 32319833 [TBL] [Abstract][Full Text] [Related]
13. Plazomicin: an investigational therapy for the treatment of urinary tract infections. Karaiskos I; Souli M; Giamarellou H Expert Opin Investig Drugs; 2015; 24(11):1501-11. PubMed ID: 26419762 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains. Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381 [TBL] [Abstract][Full Text] [Related]
15. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents. Almaghrabi R; Clancy CJ; Doi Y; Hao B; Chen L; Shields RK; Press EG; Iovine NM; Townsend BM; Wagener MM; Kreiswirth B; Nguyen MH Antimicrob Agents Chemother; 2014 Aug; 58(8):4443-51. PubMed ID: 24867988 [TBL] [Abstract][Full Text] [Related]